DIN 02438577 — FLUDARABINE PHOSPHATE INJECTION, USP 25 MG
FLUDARABINE PHOSPHATE INJECTION, USP is a solution of Fludarabine marketed by ACCORD HEALTHCARE INC. The full Fludarabine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02438577
- Brand name
- FLUDARABINE PHOSPHATE INJECTION, USP
- Active ingredient
- Fludarabine
- Strength
- 25 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- ACCORD HEALTHCARE INC
- Health Canada status
- MARKETED
- Drug class
- Purine nucleoside analogue antineoplastic (antimetabolite chemotherapy agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fludarabine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02246226 | FLUDARA | 10 MG | TABLET | SANOFI-AVENTIS CANADA INC | MARKETED |
| 02283859 | FLUDARABINE PHOSPHATE FOR INJECTION | 25 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02351722 | FLUDARABINE PHOSPHATE INJECTION | 25 MG | SOLUTION | FRESENIUS KABI CANADA LTD | DORMANT |